GUOBANG PHARMA was founded in 1996 and went public in 2021 (stock code 605507.SH). The company is a pharmaceutical manufacturing enterprise that targets the global market, offers a variety of products, and has the self-production capacity of multiple key intermediates. It is a top 100 pharmaceutical enterprise in China. The company focuses on pharmaceutical chemical technology as its core, concentrates on life health active substances, and is dedicated to human medicine, animal health care, plant protection, functional nutrition, rehabilitation and health care, etc. It focuses on developing in the main functional regions of the region and strives to become a leading enterprise in multiple varieties in the global pharmaceutical manufacturing industry. 

      The company has established modern production bases in two national-level industrial parks in Shangyu, Zhejiang Province and Weifang, Shandong Province. Its products have obtained international market certifications such as the FDA of the United States, EUGMP of the European Union, PMDA of Japan, and ANVISA of Brazil. The company adheres to a dual-drive strategy of both domestic and international markets, has a global sales network, and its products are sold to 6 continents, 117 countries and regions around the world. It has over 5,000 supply and sales partners and serves nearly 7 billion people. Currently, the company has over 2,500 acres of operating land, 4,300 employees, has obtained 220 authorized patents, and has a total asset of nearly 11 billion yuan. In 2025, its annual revenue will be 6.011 billion yuan and its net profit after parent company's deduction will be 821 million yuan. 

      In the future, the company will continue to uphold the industry mission of "Sharing the beauty of science, nature and life", adhere to the goal of "Scientific innovation, becoming a leading enterprise in varieties", and strive to build "The world's supporting factory for healthy active products", so that those who cannot afford medicine can afford it, those who cannot access medicine can obtain it, and serve the lives and health of more people around the world.